Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies

Clinical trial NCT00070239 · TERMINATED

Trial details

NCT number: NCT00070239
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematopoietic/Lymphoid Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2003-08-01
Primary completion: 2006-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.